A Novel Metabolic Score for Insulin Resistance and Symptomatic Intracranial Hemorrhage in Ischemic Stroke Patients After Endovascular Thrombectomy
Shuaiyu Chen,Yan E,Xiaohao Zhang,Bin Wei,Siyu Wang,Zhaohan Xu,Pengyu Gong,Yi Xie,Chunhua Qin,Yingdong Zhang
DOI: https://doi.org/10.2147/NDT.S394438
IF: 2.989
2023-02-05
Neuropsychiatric Disease and Treatment
Abstract:Shuaiyu Chen, 1, &ast Yan E, 1, &ast Xiaohao Zhang, 1, &ast Bin Wei, 1 Siyu Wang, 1 Zhaohan Xu, 1 Pengyu Gong, 2 Yi Xie, 3 Chunhua Qin, 1 Yingdong Zhang 1 1 Department of Neurology, Nanjing First Hospital, Nanjing Medical University, Nanjing, People's Republic of China; 2 Department of Neurology, Affiliated Hospital of Nantong University, Nantong, People's Republic of China; 3 Department of Neurology, Jinling Hospital, Medical School of Nanjing University, Nanjing, People's Republic of China &astThese authors contributed equally to this work Correspondence: Chunhua Qin; Yingdong Zhang, Department of Neurology, Nanjing First Hospital, Nanjing Medical University, No. 68 Changle Road, Nanjing, People's Republic of China, Tel/Fax +86 2552271000, Email ; Background and Purpose: Insulin resistance plays a pivotal role in the pathophysiology of ischemic stroke. This study aimed to determine the relationship between the novel metabolic score for insulin resistance (METS-IR) and symptomatic intracranial hemorrhage (sICH) after endovascular thrombectomy (EVT) in stroke patients. Methods: We retrospectively included patients with large artery occlusion in the anterior circulation and treated by EVT from 2 stroke centers (Nanjing First Hospital from September 2019 to April 2022, and Jinling Hospital from September 2019 to July 2021). The METS-IR was used as an alternative marker of insulin resistance and calculated using laboratory data after admission. sICH was diagnosed according to the Heidelberg Bleeding Classification. Results: Of the 410 enrolled patients (mean age, 69.8 ± 11.7 years; 60.7% men), 50 (12.2%) were diagnosed as sICH. After adjusting for demographic characteristics, poor collateral status, and other potential confounders, higher METS-IR was revealed to be independently associated with sICH (odds ratio, 1.076; 95% confidence interval, 1.034− 1.120; P = 0.001). Similar significant results were obtained when defining METS-IR as a categorical variable. The restricted cubic spline uncovered a linear relationship between METS-IR and sICH ( P < 0.001 for linearity). Furthermore, adding METS-IR to the conventional model significantly improved the risk prediction for sICH (net reclassification improvement = 15.8%, P = 0.035; integrated discrimination index = 2.6%; P = 0.017). Conclusion: This study demonstrated a significant association between METS-IR score and sICH in ischemic stroke patients treated with EVT. It could help monitor and manage sICH in patients after EVT. Keywords: METS-IR, insulin resistance, ischemic stroke, symptomatic intracranial hemorrhage, endovascular thrombectomy Several randomized controlled trials have revealed that endovascular thrombectomy (EVT) substantially improves the outcome of ischemic stroke patients caused by a large vessel occlusion in the anterior circulation. 1 Nevertheless, successful recanalization by EVT does not always translate into a good outcome for patients. Symptomatic intracranial hemorrhage (sICH) is one of the feared complications, which may occur in 16% of Asian patients and reduce the benefit-risk ratio of EVT. 2–5 Therefore, early and accurate identification of sICH is of substantial clinical importance for continuously improving the prognosis after EVT. It has been reported that insulin resistance is the main pathophysiological determinant of type 2 diabetes. 6 Insulin resistance may increase the risk of metabolic syndrome and atherosclerotic cardiovascular diseases. 7,8 Some preliminary studies indicated that higher insulin resistance was correlated with poor outcome in stroke patients after thrombolytic treatment. 9,10 At present, insulin resistance can be evaluated by many methods. The euglycaemic-hyperinsulinaemic clamp technique is the gold standard for measuring insulin resistance. However, it is unsuitable for epidemiological studies due to its complex, expensive, and invasive shortcomings. 11 Given this limitation, several non‐insulin‐based insulin resistance scores, which combined simple routine biochemical indicators such as triglyceride to high-density lipoprotein cholesterol ratio and triglyceride glucose index, have been developed. 12–14 Nevertheless, these indexes ignore the role of nutritional status in insulin sensitivity. Recently, Bello-Chavolla et al established a novel metabolic score of insulin resistance (METS-IR), which showed a higher concordance with the euglycaemic-hyperinsulinaemic clamp in assessing insulin resistance. 15 Several studies have -Abstract Truncated-
psychiatry,clinical neurology